Human immunodeficiency virus type‐1 reverse transcriptase and ribonuclease h as substrates of the viral protease
- 31 December 1993
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 2 (12) , 2167-2176
- https://doi.org/10.1002/pro.5560021216
Abstract
A study has been made of the susceptibility of recombinant constructs of reverse transcriptase (RT) and ribonuclease H (RNase H) from human immunodeficiency virus type 1 (HIV‐1) to digestion by the HIV‐1 protease. At neutral pH, the protease attacks a single peptide bond, Phe440‐Tyr441, in one of the protomers of the folded, active RT/RNase H (p66/p66) homodimer to give a stable, active heterodimer (p66/p51) that is resistant to further hydrolysis (Chattopadhyay, D., et al., 1992, J. Biol. Chem. 267, 14227–14232). The COOH‐terminal p15 fragment released in the process, however, is rapidly degraded by the protease by cleavage at Tyr483‐Leu484 and Tyr532. Leu533. In marked contrast to this p15 segment, both p66/p51 and a folded RNase H construct are stable to breakdown by the protease at neutral pH. It is only at pH values around 4 that these latter proteins appear to unfold and, under these conditions, the heterodimer undergoes extensive proteolysis. RNase H is also hydrolyzed at low pH, but cleavage takes place primarily at Gly436‐Ala437 and at Phe440‐Tyr441, and only much more slowly at residues 483, 494, and 532. This observation can be reconciled by inspection of crystallographic models of RNase H, which show that residues 483, 494, and 532 are relatively inaccessible in comparison to Gly436 and Phe440. Our results fit a model in which the p66/p66 homodimer exists in a conformation that mirrors that of the heterodimer, but with a p15 segment on one of the protomers that is structurally disordered to the extent that all of its potential HIV protease cleavage sites are accessible for hydrolysis.Keywords
This publication has 43 references indexed in Scilit:
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Large scale purification and refolding of HIV-1 protease fromEscherichia coli inclusion bodiesProtein Journal, 1993
- Fibronectin is a non‐viral substrate for the HIV proteinaseFEBS Letters, 1991
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteinsFEBS Letters, 1991
- Non‐viral cellular substrates for human immunodeficiency virus type 1 proteaseFEBS Letters, 1991
- Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinasesBiochemical and Biophysical Research Communications, 1990
- Sub‐site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV‐1FEBS Letters, 1990
- Substitutions at the P2′ site of gag p17–p24 affect cleavage efficiency by HIV-1 proteaseBiochemical and Biophysical Research Communications, 1990
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970